Skip to main content
Submitted by Dr S. Patel on 12 January 2019
Image: Fingers pointing at a Bone Scan Image

What is a Bone Scan? What do the results of the scan indicate? When do you need a Bone Scan? How often should you get a Bone Scan? We give you information that will help you discuss your options with your doctor.

What is a Bone Scan 

A Bone scan is done to check the bone mineral density (BMD) so as to assess strength of the bones and probability of any fractures. The scan helps identify any mild (osteopenia) or serious bone loss (osteoporosis). The most common bone density test is the DEXA scan. Here, the entire body is scanned after a tiny amount of radioactive substance called a tracer is injected into a vein. Since the DEXA test scans the entire body, it is able to detect and diagnose a wide range of bone disorders.

Since the bone scan is a nuclear medicine test, excessive exposure to tracers is not recommended. Although, some doctors may argue that the amount of radiation exposure is minute and hence not harmful. The bone scan generally has no side-effects and follow-up care is not required. Any radioactivity from the tracers used get eliminated within two days post the scan.

So who should get a DEXA scan:

  • Women above the age of 65
  • Men above the age of 70

If you are younger than the above age group, your doctor may suggest it if you have the following risk factors:

  • Early menopause or late-onset of menstrual periods.
  • You smoke or drink heavily
  • You have a history of rheumatoid arthritis
  • You have a parent who had hip or other fractures
  • You have low body weight or small body frame
  • Take medications that cause bone loss such as steroids, anti-seizure drugs etc.
  • You have been on cancer treatment like hormonal treatment, chemotherapy
  • Have low estrogen levels
  • Have hyperparathyroidism
  • Have hyperthyroidism
  • Have chronic Vitamin D deficiency.

Let’s look at some other instances when a bone scan is required:

  • If a patient complains of unexplained skeletal pain.
  • Fractures from minor accidents.
  • History of corticosteroid use for more than 3 months.
  • Paget’s disease of bone.
  • Suspicion of a bone infection or bone disease that is unclear on a regular X-ray.
  • To find any cancer originating from the bone
  • To check for metastasis (spread of cancer) in the bones from other areas.
  • To monitor progress of treatment for Bone Cancer.

What do the DEXA Test results mean:

A Radiologist will look for abnormal bone shadows on the images. Dark areas which take up more tracer are termed “hot spots” and light ones with less tracer are the “cold spots”. Areas of fast bone growth, cancer, infections, trauma or repair show up as dark spots (figure b).

The scan also compares the patient’s bone mineral density values (T-score) to those of a young 30 year old normal adult (Z-score). The image below shows what your T-score result means.

How often should you get a bone scan?

There is no fixed interval for scanning of bone density. If your bones are healthy, your doctor may suggest a scan after 15 years. This comes from a 2012 study that reported that bone loss in average women above 65 is quite slow i.e. a woman with normal bone density only loses 5% of bone density in 10 years. Women who show low or moderate density in the initial scan are likely to be more osteoporotic. For such women, testing is recommended every 5 to 1 year depending on their T-score. Best to follow your doctor’s recommendations on when to get a scan depending on your risk factors and medical history.

Updated for cancer treatment on 12th January 2019

Changed
Sat, 01/12/2019 - 15:13

Stories

  • Osteoporosis
    is a common condition, usually seen in the elderly, of diminished bone mass and low bone weight, which leads to fragile bones. Bones are living tissue constantly being broken down and rebuilt by the body. During childhood and youth, you form new bone faster than you lose old bone. Between the ages of 18 and 30, you reach peak bone mass. As people age, bone loss increases. Osteoporosis occurs when the body doesn’t create enough new bone to keep up with the absorption or…
  • Mayo Clinic partners with IBM to match Cancer Patients with Clinical Trials
    Mayo Clinic unveiled today a partnership with IBM to harness the power of its Watson supercomputer to match patients with the right clinical trials. Starting early next year, Watson will initially enroll patients with breast, colorectal and lung cancers based on eligibility. There are 170,000 ongoing clinical trials around the world, however, according to the Center for Information and Study on Clinical Research Participation, only 6% are completed on time. Enrolling patients in the…
  • FDA approves first use of novel immune system drug for cancer
    This new class of drugs unleashes the body's immune system to fight tumors. This seems to solve a century-old mystery of how cancerous cells manage to evade the body's immune system. The drug which Merck will sell under the name of Keytruda was approved by patients with advanced melanoma who have exhausted other therapies.  http://www.nytimes.com/2014/09/05/business/merck-wins-approval-of-novel-immune-system-drug-for-cancer.html?emc=eta1
  • Tofacitinib: A novel oral treatment for rheumatoid arthritis
    Tofacitinib (Xeljanz®) is the first of a unique class of oral kinase inhibitors to be FDA approved for the treatment of rheumatoid arthritis (RA). Tofacitinib is a selective inhibitor of Janus kinase (JAK) enzymes. these enzymes mediate signaling for several important cytokines that cause the inflammation in Rheumatoid Arthritic patients.  http://www.hopkinsarthritis.org/arthritis-news/tofacitinib-fda-approved-oral-biologic-for-rheumatoid-arthritis/
  • Do more for depressed cancer patients
    Clinical depression was much more prevalent among cancer patients than in the general population, where around 2% of people suffer from the mental illness at any point in time. Among cancer patients, clinical depression ranged from 13% in people with lung cancer to 6% in people with genitourinary cancer. The study's lead author Michael Sharpe, from Oxford University, said: "Major depression is really quite common in people with cancer and the perhaps surprising finding is that most of it goes…
  • Is Knee or Hip replacement right for you ?
    How many times has someone close to us been told to replace a knee or replace a hip ? But is it always the right option ? Understand and evaluate your options carefully as explained here :  http://health.clevelandclinic.org/2014/08/is-a-hip-or-knee-replacement-right-for-you/
  • Exercising with Arthritis? Is it possible?
    A great article on why exercising is important to prevent complications from inactivity in Arthritic patients and what exercises are suitable. https://www.rheumatology.org/Practice/Clinical/Patients/Diseases_And_Conditions/Exercise_and_Arthritis/
  • Cancers can be prevented if people kept to a normal weight
     Excess weight linked to 10 different cancers Cancers have many causes – some of them genetic and some environmental. But the researchers, from the London School of Hygiene and Tropical Medicine (LSHTM) and the Farr Institute of Health Informatics, have taken account of all the other factors involved in order to come up with a good estimate of the actual number of cancers that could be prevented if people kept to a normal weight. http://www.theguardian.com/society/2014/aug/14/excess-weight…
  • Men get Arthritis, too
    Living with RA is living with pain but “Don’t let the disease define you”. RA causes pain in his hands, but he plays the piano every day to keep his fingers moving and his brain active. http://www.everydayhealth.com/news/men-get-arthritis-too/?xid=tw_everydayhealth_sf
  • New research from A*STAR for early detection and personalised treatment of Ovarian Cancer
    There are no early stage diagnostics for ovarian cancer and by the time they are discovered, they may not respond to standard cancer treatments.  But a new research from A*STAR's Institute of Medical Biology (IMB) and the Bioinformatics Institute (BII) have found new clues to early detection and personalized treatments of ovarian cancer, thus offering hope to millions of women who might be susceptible to it. Their findings were published online in Nature Cell Biology in July…